Assessment of Minimal Residual Disease in Standard-Risk AML

N Engl J Med. 2016 Aug 11;375(6):e9. doi: 10.1056/NEJMc1603847.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Leukemia, Myeloid, Acute / genetics*
  • Mutation*
  • Nuclear Proteins / genetics*

Substances

  • Nuclear Proteins